AI Business is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Health & Pharma

Roche introduces AI-based algorithm to diagnose non-small cell lung cancer

by Chuck Martin
Article ImageUnique to its uPath enterprise software for digital pathology

Swiss pharmaceutical giant Roche has launched an automated digital pathology algorithm to provide image analysis for diagnosing non-small cell lung cancer.

The uPath PD-L1 (SP263) image analysis aims to provide pathologists with automated assessments of scanned slide images, with the potential to aid diagnosis and target treatment options.

The product has obtained European CE Marking for In Vitro Diagnostic devices (CE-IVD), which means it has been certified to be used the EU, European Free Trade Area (EFTA), Switzerland, Turkey, and some other countries.

The algorithm is being integrated within Roche uPath enterprise software for digital pathology, a universal digital platform for case management, collaboration, and reporting, which was launched in January.

AI in production

The new AI-based feature can help pathologists quickly determine if tumours in a patient are positive for the PD-L1 biomarker, which may make them eligible for targeted treatment.

“Improving diagnostic consistency and certainty is crucial in providing faster, higher-quality, and more accurate diagnoses to cancer patients,” said Thomas Schinecker, CEO of Roche Diagnostics. “Our uPath PD-L1 (SP263) image analysis is the first next-generation CE-IVD PD-L1 algorithm to the clinical market.

“It expands on our growing digital pathology suite for Ventana assays that aid physicians in providing the most accurate treatment decisions for patients with the most common type of lung cancer.”

The Roche system focuses on delivering “end-to-end digital pathology solution from tissue staining to producing high-quality digital images that can be reliably assessed using automated clinical image analysis algorithms.”

The AI-enabled uPath system is an example of traditionally research-oriented tools moving into routine clinical practice.

Lung cancer is the leading cause of cancel deaths globally, according to the World Health Organization

Practitioner Portal - for AI practitioners


Shaping AI and analytics services


AI and analytics teams must market themselves – and they have to have a clear service strategy


UK's ICO publishes guidance on AI and data protection


The document aims to help organizations mitigate the risks of using personal data in AI applications

Practitioner Portal


More EBooks

Upcoming Webinars

More Webinars

Experts in AI

Partner Perspectives

content from our sponsors

Research Reports

More Research Reports


AI tops the list of most impactful emerging technologies

Infographics archive

Newsletter Sign Up

Sign Up